首页> 外国专利> STREPTAVIDIN MUTANTS HAVING SECONDARY FUNCTIONAL DOMAINS

STREPTAVIDIN MUTANTS HAVING SECONDARY FUNCTIONAL DOMAINS

机译:链霉抗生物素突变体具有第二功能区

摘要

Streptavidin molecules are disclosed that contain a secondary functionaldomain. In preferred embodiments, the secondary domainis a cell adhesion peptide incorporated in the streptavidin amino acidsequence at a site not interfering with biotin binding. In a preferredembodiment, the cell adhesion peptide is arginine-glycine-aspartate (Arg-Gly-Asp)(RGD). The peptide is preferably placed on an exposedloop of the streptavidin molecule, such as within the loop defined by residues63 to 69. The mutant streptavidin molecule can have othercharacteristics such as reduced biotin binding due to a modification of anamino acid at the biotin binding site. Preferred uses for thedisclosed streptavidin molecules are as adaptors to bring, via astreptavidin/biotin interaction, the secondary functional domain intoproximitywith a cell or molecule to be effected and as a coating for substrates such asvascular devices or prostheses.
机译:公开了含有次级功能的链霉亲和素分子域。在优选的实施方案中,二级结构域是掺入链霉亲和素氨基酸的细胞粘附肽在不干扰生物素结合的位点的序列。在首选实施方案中,细胞粘附肽是精氨酸-甘氨酸-天冬氨酸(Arg-Gly-Asp)(RGD)。肽最好放在暴露的地方链霉亲和素分子的环,例如在残基定义的环内63至69。突变链霉亲和素分子可以具有其他特性,例如由于修饰的生物素而减少的生物素结合生物素结合位点的氨基酸。的首选用途公开的链霉亲和素分子作为衔接子通过链霉亲和素/生物素相互作用,二级功能域进入接近带有待影响的细胞或分子,并作为底物(例如)的涂层血管装置或假体。

著录项

  • 公开/公告号CA2340595A1

    专利类型

  • 公开/公告日2000-03-02

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF WASHINGTON;

    申请/专利号CA19992340595

  • 申请日1999-08-25

  • 分类号C12N15/00;A61K38/16;A61L27/34;C07K14/36;C12N11/02;G01N33/48;G01N33/531;G01N33/58;

  • 国家 CA

  • 入库时间 2022-08-22 01:52:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号